Article Information
History
- May 12, 2020.
Article Versions
- Version 1 (May 5, 2020 - 07:27).
- You are currently viewing Version 2 of this article (May 12, 2020 - 09:54).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Theodoros Evgenioua,*,
- Mathilde Fekomb,
- Anton Ovchinnikovc,
- Raphael Porcherd,
- Camille Pouchole and
- Nicolas Vayatisf
- aINSEAD, Bd de Constance, 77300 Fontainebleau, France
- bUniversité Paris-Saclay, ENS Paris-Saclay, CNRS, Centre Borelli, 94235 Cachan, France
- cSmith School of Business, Queen’s University, Kingston, ON, K7L3N6, Canada
- dUniversité de Paris CRESS, INSERM, INRA, 75004 Paris, France
- eMAP5 Laboratory, FP2M, CNRS FR 2036, Université de Paris, 75006 Paris, France
- fUniversité Paris-Saclay, ENS Paris-Saclay, CNRS, Centre Borelli, 94235 Cachan, France
- ↵*Corresponding author; email: theodoros.evgeniou{at}insead.edu
Posted May 12, 2020.
Epidemic Models for Personalised COVID-19 Isolation and Exit Policies Using Clinical Risk Predictions
